Laboratori FUNDACIO DAU Pharmadox Healthcare Ltd. Wessling Hungary Ltd.

Poland

All drugs from this manufacturer

  • GEFITINIB ACCORD

    The medicine is intended for the treatment of adult patients with non-small cell lung cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    gefitinib 250 mg

    ATC: L01EB01